MAYO CLINIC
Government Contracts & Awards
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
GE HealthCare and Mayo Clinic aim to advance personalized cancer treatment through new theranostics research collaboration
CHICAGO & ROCHESTER, Minn., July 08, 2026--GE HealthCare and Mayo Clinic today announced the MI-BET (Molecular Imaging Biomarker-Based End of Therapy Trial) research collaboration, a novel theranostics study designed to explore a more personalized approach to radioligand therapy (RLT) for patients with advanced prostate cancer. This collaboration is a direct result of the 2023 Strategic Radiology Research Alliance between Mayo Clinic and GE HealthCare, aimed at transforming the experience of pat
GE HealthCare And Mayo Clinic Announce MI-BET Research Collaboration, Theranostics Study To Explore Personalized Approach To Radioligand Therapy For Advanced Prostate Cancer Patients
A novel theranostics study explores imaging- and data-informed approaches to support individualized treatment decisions and expand access to theranosticsCollaboration stems from a 2023 Strategic Radiology Research
Microsoft Deepens In House AI And Healthcare Focus At Build 2026
Microsoft (NasdaqGS:MSFT) used Build 2026 to unveil seven in house AI models, led by its new MAI-Thinking-1 reasoning model. The company outlined deeper AI collaborations in healthcare and scientific research, including Mayo Clinic, Causaly, First Foundation Labs, and Cortechs.ai. Management highlighted a plan to rely more on proprietary models and reduce dependence on external partners such as OpenAI. For investors watching Microsoft’s AI plans, Build 2026 adds new detail to how the...
Microsoft Deepens Healthcare AI Push And Eases OpenAI Reliance For Investors
Microsoft (NasdaqGS:MSFT) has launched new healthcare and life sciences AI collaborations, including a frontier clinical reasoning model co-developed with Mayo Clinic. The company also announced partnerships with Cortechs.ai, First Foundation Labs, and Causaly to embed advanced AI into clinical workflows and R&D. Microsoft introduced seven new in-house AI models, including its first reasoning model, MAI-Thinking-1, developed by its superintelligence team. The company restructured its OpenAI...
Medable CEO Michelle Longmire Featured as Guest Speaker with Leaders from Google and Mayo Clinic at Japan’s Largest Pharmaceutical Summit
PALO ALTO, Calif., May 06, 2026--Medable Inc., the leading technology platform for agentic AI clinical development, today announced that its CEO and co-founder, Dr. Michelle Longmire, will be one of three international guest speakers at Japan’s largest pharmaceutical conference, Ubie Pharma Summit (May 13-14, 2026). Longmire will be speaking at the fifth annual event along with Justin Chen, MD, Clinical Specialist at Google for Health, and John Halamka, MD, President of Mayo Clinic Platform.
Key People
No individuals linked to this entity yet.
Political Giving
No disclosed PAC contributions found for this entity.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro